Clinical Trial Update: Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intranasal teriparatide on the bone formation biomarker P1NP in postmenopausal women with low bone mass. The study includes pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• Teriparatide intranasal (teriparatide)

Snippet

Sponsor: Azelon Pharmaceuticals | Conditions: Osteoporosis, Osteopenia | Phase 2 | Status: UNKNOWN